Effects of Dietary Phenobarbital on the Binding of 2-Acetylaminofluorene to Rat Liver Nuclear DNA
Phillip S. Mushlin, Carl Peraino
Abstract
Phillip S. Mushlin, Carl Peraino
Abstract
Previous studies have shown that dietary phenobarbital reduces 2-acetyl-aminofluorene (AAF)-induced hepatic tumorigenesis when fed simultaneously with the carcinogen, but enhances tumorigenesis when fed after the cessation of AAF feeding. Since DNA may be a primary target of chemical carcinogens, the effects of phenobarbital on the binding in vivo of AAF metabolites to hepatic nuclear DNA were investigated. The results show that the prolonged feeding of phenobarbital prior to the injection of AAF-9-14C reduced the binding of label to DNA, but the binding of label was not reduced if phenobarbital feeding was begun after the injection of AAF.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Previous studies have shown that dietary phenobarbital reduces 2-acetyl-aminofluorene (AAF)-induced hepatic tumorigenesis when fed simultaneously with the carcinogen, but enhances tumorigenesis when fed after the cessation of AAF feeding. Since DNA may be a primary target of chemical carcinogens, the effects of phenobarbital on the binding in vivo of AAF metabolites to hepatic nuclear DNA were investigated. The results show that the prolonged feeding of phenobarbital prior to the injection of AAF-9-14C reduced the binding of label to DNA, but the binding of label was not reduced if phenobarbital feeding was begun after the injection of AAF.
Key concepts: Phenobarbital, 2-Acetylaminofluorene, Carcinogen, Carcinogenesis, DNA, Chemistry, In vivo, Internal medicine